A prospective descriptive 1-year study in France of all BCG therapy dispensations for non-muscle-invasive bladder cancer.

Yann Neuzillet,Priscilla Leon,Thomas Seisen,Yves Allory,François Audenet,Yohann Loriot,Alexandra Masson-Lecomte,Arnaud Mejean,Benjamin Pradère,Mathieu Roumiguié,Olivier Traxer,Evanguelos Xylinas,Georges Fournier,Morgan Roupret

BJU international（2023）

引用 1|浏览32

暂无评分

摘要

Our data suggest that the incidence of NMIBC at high risk of recurrence and progression is underestimated in reference epidemiological studies. These results should help to better define future care needs.

查看译文

关键词

adjuvant treatment,bladder cancer,carcinoma in situ,induction therapy,intravesical BCG,maintenance therapy,non-muscle-invasive bladder cancer,prescriptions,recurrence,risk

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要